Doctor's Life Simulator

Chapter 362 Pfizer launched an attack, and Ming's Pharmaceutical Group fell into crisis

Hearing Director Huang's words, the surrounding doctors were also shocked.

Qin Lang has actually reached the level of being able to publish textbooks, and it is also a heart transplant surgery that ranks among the top ten most difficult surgeries in surgery.

"Director Qin, congratulations."

"Director Qin, you are amazing!"

In the department, all the doctors gathered around, all kinds of congratulations and envy.

Qin Lang was not too surprised by this, after all, when writing this expert report, he was mentally prepared.

However, Qin Lang is still very happy. After all, it is a supreme honor to be included in the medical textbooks of colleges and universities.

From then on, his name will be ranked with the top and most senior professors and academicians, and he will become one of the industry giants in the medical field.

At least, in the field of heart transplant surgery, Qin Lang is already the top expert in the country, and he can be regarded as the founder of the school.

[Ding, a new achievement, the compiled specification was selected as a college textbook, rewarding life simulation points: 3 points. 】

In the next few days, Qin Lang entered his daily life again.

During a week, I will spend three days in Hangzhou. In addition to studying cardiovascular medicine, I will control the progress of new drug research and development. With the dedicated efforts of Wang Rou's team, the research and development of smoking cessation drugs is steadily advancing.

In the remaining few days, Qin Lang will return to the City No. [-] Hospital. Now Qin Lang's prestige and status will be further improved with the selection of college textbooks.

Among the first hospitals in the city, Qin Lang can move more freely. The emergency department, cardiology department, burn department, general surgery department, and several departments will take turns to be on duty, and will be invited to give guidance if necessary.

After Qin Lang entered a normal pace of life, Ming's Pharmaceutical Group in Hangzhou was also beaming from employees to the board of directors these days.

The entire company, because of Qin Lang's amazing performance at the Huaguo Heart Conference and the progress of the blockbuster new drug at the press conference, caused the stock price of the entire company to soar.

Taking this opportunity, Chairman Ming also increased his investment. He added an additional investment to the research and development of new drugs with the First Affiliated Hospital of Zijingang University, and purchased more top-notch international equipment.

In his own group, he also took advantage of this wind and the recent success to enter a new round of research and development of smoking cessation drugs.

In the board of directors, some people also expressed negative opinions on Ming Dong's desperate behavior. They felt that such investment, if the research and development of smoking cessation medicine failed in the end, it would be a major blow to the group.

However, Chairman Ming is still going to insist, one is that this nicotine-free smoking cessation drug was first released in Huaguo and even in the world, which is a milestone.The second is that the market for smoking cessation drugs in China is a blue ocean, which is worth exploring.Once successful, Ming's Pharmaceutical Group will enter an explosive period with a bright future.

Although Ming's Pharmaceutical Group is the top pharmaceutical company in Zhejiang Province, they are basically generic drugs and agents, and do not have a core product of their own. Therefore, the world's first nicotine-free smoking cessation drug this time is also one of Ming Dong's products. A work of ideals and ambitions.

Under Ming Dong's insistence, finally Ming's Pharmaceutical Group firmly implemented the plan and invested a lot of money into it.

Pfizer's office in Zhejiang Province.

In the regional general manager's office, Wanfeng and his secretary had just completed a vigorous exercise to vent their frustration.

After all, during this period of time, Ming's Pharmaceutical Group was in the limelight, the company's stock price soared, and that woman Ming Dong was even more proud.

This made Wanfeng very unhappy.

A photo of Ming Dong's head portrait was specially printed and worn on the secretary's face, Wanfeng had a violent meal.

A minute and a half later, Wanfeng walked out of the darkroom of the office, came to his desk, and clicked on an email.

After reading it, the whole person was ecstatic:

"The brand new smoking cessation drug at the headquarters: Chantix, has successfully completed the third phase of clinical trials, and within a week, it will be able to obtain FDA approval. Wait until the day when the new drug is launched, I want to see it, you Ming What is the face of the pharmaceutical group?"

When Wan Feng thought of it, Ming Dong's expression of despair and frustration was a burst of excitement.

"In addition to the launch of the new drug, I also need to contact the muddy water organization in the United States, provide various information about Ming's Pharmaceutical Group, and ask them to make a short-selling report. At that time, I will properly suppress Ming's Pharmaceutical Group. .”

Wanfeng is an old fritter with rich business skills.

As long as it is a means that can hit the opponent, he will use it.

In the next few days, Wanfeng devoted himself to intensive preparations, and this time, he was confident that he would be able to drive Ming's Pharmaceutical Group to the bottom and never turn back again.

Wanfeng looked at the homepage of Ming's Pharmaceutical Group's official website and saw the latest information of their company, and sneered again and again.

In particular, the largest picture is the new drug research and development laboratory project jointly established by Mingshi Pharmaceutical Group and the First Affiliated Hospital of Zijingang University.

Looking at the young doctor who is the core in the picture, Wan Feng chuckled a few times:

"Really think that such a young doctor can develop new anti-tumor drugs? So far, it has only completed the so-called phase I clinical trials, and there is still a long way to go."

Wanfeng was a little disgusted with Qin Lang, a young man. After all, it was this little doctor who repeatedly ruined his affairs. The previous inbred mouse project made him lose face.

Recently, Ming's Pharmaceutical Group's prosperity is boundless, and its source is also this hateful brat.

"During the interview at the Heart Congress, you also boldly proposed that you are developing a brand new new drug that is the first in Huaguo, and it has entered the third phase of clinical trials, and it will be on the market soon?"

For this, Wanfeng scoffed. Speaking of which, Pfizer’s smoking cessation drug is about to be launched. If that little guy really has a new drug, Wanfeng also wants to fight him and let him know, know, Pfizer The strength of the world's top pharmaceutical giant!

"Ming Dong, in a few days, I will trample you under my feet on the project that you value the most and put the most effort and energy into."

Thinking of this, Wanfeng pulled out his own drawer on a whim again. There was a small electric bell inside, and he pressed it.

This bell is connected to the secretary's office next door.

After ringing the bell, Wanfeng entered the dark room behind the office again after a while.

Another minute and a half later, Wanfeng walked out a little tired.

half a month later.

In Washington, USA, Pfizer Pharmaceuticals Group held a press conference. At the meeting, a world-first new drug was launched, a brand new nicotine-free smoking cessation drug: Chantix!

At the meeting, Pfizer comprehensively introduced this new drug, which is a new type of non-nicotine smoking cessation drug, and the entire smoking cessation cycle is 12 weeks. Partial agonists of the body, similar in structure to nicotine, can bind to nicotine receptors, and after binding, nerve cells release much less dopamine.

It is a brand-new preparation with significant curative effect, curbing smoking addiction and preventing relapse. It is divided into two dosage forms of 0.5mg and 1mg tablets. The dosage recommended by FDA is 2mg/d (1mg, 2 times/d).
For the birth of this brand new smoking cessation drug, the medical field was naturally shocked.

Moreover, according to Pfizer's plan, in addition to Omi, it will also enter [-] countries including Huaguo, Singapore, and Thailand.

The name of this brand new smoking cessation drug after it entered Huaguo is: Changpei!
And after the release of this brand new smoking cessation drug, the entire medical circle in Huaguo was shocked.

All the Huaguo Pharmaceutical Group lamented that Pfizer is the top in the industry, and it is another new drug.

Zhejiang Province, Mingshi Pharmaceutical Group.

Jin Yun'er was completely dumbfounded. As Chairman Ming's secretary, she was of course very well informed about the news in the pharmaceutical industry.

At the first time, she watched the live video of Pfizer's press conference, and after seeing that Pfizer's new drug this time was a brand-new smoking cessation drug that did not contain nicotine, Jin Yun'er was shocked.

This is not an area where Ming's Pharmaceutical Group has spent a lot of money and a lot of time in research and development. How could Pfizer launch this new drug before Ming's Pharmaceutical Group.

According to Pfizer's strength, this new drug will soon enter the Huaguo market, which is a devastating blow to Ming's Pharmaceutical Group.

Jin Yun'er walked into Chairman Ming's office somewhat distraught.

Ming Dong was in a good mood recently because the company's stock price soared. When he saw Jin Yuner coming in, he frowned with panic on his face.

"Xiao Jin, what's the matter? The whole person is so flustered."

Ming Dong's tone was flat, he took a sip of scented tea, and looked at his secretary.

"Ming Dong, there is very bad news. I also just learned that Pfizer Pharmaceuticals held a brand new new drug conference today and released a new drug."

Jin Yun'er didn't know how to tell Dong Ming the bad news.

"Pfizer released a new drug? What new drug? Let me see."

Ming Dong has been busy with various company matters recently, so he didn't take the time to understand Pfizer's press conference.

After all, now, all her energy and heart are spent on the research and development of Ming's Pharmaceutical Group's own brand-new smoking cessation drug.

Jin Yuner handed over the phone with some hesitation.

"Ming Dong, don't be too angry."

Ming Dong took Jin Yaner's mobile phone, looked at it intently, and then his whole face turned pale.

"How is it possible, how is it possible!"

Dong Ming's heart sank by more than half. After all, she had invested all her human, material and financial resources in this research and development project of smoking cessation medicine.

However, the whole project is about to see hope. How could she expect Pfizer to take the lead.

"It has passed all phases of clinical trials, and it has also been approved by the US FDA. It will enter the Huaguo market in the near future. Even the product name of Huaguo has been chosen."

Ming Dong lost his mind for a while, which was really a big blow to her.

As the chairman of a group, the project he promoted under his promise has encountered an unprecedented failure.

Of course she couldn't shirk the blame. How quick Ming Dong's thinking was, he had already thought of a series of things that would happen because of this press conference.

"No, I need to convene the board of directors immediately to completely block the information that our company is desperately investing in the research and development of smoking cessation drugs."

Ming Dong can only cut off his wrists now, and take down the entire smoking cessation drug project immediately.

All research and development stages are stopped to minimize losses. With the recent rise in the stock price of Ming's Pharmaceutical Group, as long as this major decision-making error is strangled within the group, the impact can still be controlled.

As long as you give some time, you can still control the influence to a minimum.

Ming Dong has already thought of a countermeasure, which is to simply put the company's next development direction into projects in the fields of new anti-tumor drugs and ventricular corrective surgery that he has cooperated with Qin Lang.

"Simply, in addition to the smoking cessation drug project, I also invested in Qin Lang, a potential stock."

After Ming Dong had a plan, he immediately asked Jin Yuner to call all the board members.

However, Qin Lang, as a member of the board of directors of Ming's Pharmaceutical Group, also received the invitation. However, Qin Lang did not have much interest in the board meeting of Ming's Pharmaceutical Group. At the same time, he had several surgeries in hand, so he did not Not involved.

Ming Dong acted resolutely, and immediately summoned the board members of the entire company.

It's just that when Dong Ming was about to block the news and immediately change the direction of the group's next development.

Wan Feng, the person in charge of Pfizer Pharmaceuticals in Zhejiang Province, held a press conference ahead of Ming Dong, the board of directors. The entire conference was prepared half a month in advance, and it was naturally sufficient and highly targeted!
Wanfeng first praised and publicized its own new drug, and then revealed that the smoking cessation drug project that Ming's Pharmaceutical Group is currently devoting all its efforts into research and development hit their guns!
Wanfeng also specially invited the manager of Muddy Waters in the United States. Muddy Waters is a well-known short-selling agency in the world.

Before, Muddy Waters had attacked many companies with Chinese concept stocks, and even included some companies with good development in China.

In these short positions, they frequently succeeded, causing Huaguo's enterprises to suffer heavy losses.

Muddy Waters is very professional and cunning, starting with some special events, and attacking opponents in all aspects through the business model, profitability, company value, company reputation, and investor confidence of the short-selling target.

Obviously, this time Ming's Pharmaceutical Group was completely manipulated by Muddy Waters. This time, the smoking cessation drug that Ming's Pharmaceutical Group put all its efforts into was hit in the head by Pfizer, completely losing hope of a comeback.

After all, everyone knows that in the same field and the same smoking cessation drug, the products of Pfizer Pharmaceuticals have crushed domestic pharmaceutical companies in all aspects, let alone approved by the US FDA.

Moreover, the most important thing is that Pfizer's new drug has been fully launched, and it is about to enter the Chinese market, while Ming's Pharmaceutical Group's new drug has not even come out of the laboratory, and there is no clear launch node.

At the press conference, as soon as the Muddy Waters report came out, the prospects of Ming's Pharmaceutical Group dimmed in an instant.

In addition to Ming's Pharmaceutical Group, Muddy Waters even conducted a comprehensive investigation into Qin Lang and Qin's Pharmaceutical Company, which were previously launched by Ming's Pharmaceutical Group.

For Qin's Pharmaceutical Company and Qin Lang, Muddy Water's evaluation is the silver-like pewter tip that was packaged.

What new anti-tumor drugs, what Huaguo's first new drugs are just gimmicks and concepts, they only exist in the PPT report, and it is impossible to successfully market them in the short term.

In particular, the current management team of Qin's Pharmaceutical Company is still being formed, and the new general manager has just been fired by a pharmaceutical company in Zhejiang Province.

It has been less than a month since he took office, and the new management team has not been well-adjusted.It is completely a temporary team with no combat effectiveness.

As for the research and development team, it is just an attending physician in the Cancer Prevention and Control Center of Zijingang University, led by a doctoral student.

The chairman of the pharmaceutical company, Qin Lang is only a doctor in the first hospital of the city, and a master student in the First Affiliated Hospital of Zijingang University.

Do you still expect such a research and development team to come up with new drugs that can rival Pfizer?Idiots talk about dreams.

In the words of muddy water, it is just a packaged leather bag company, which cannot be listed in the elegant hall.

How could this small temporary company develop a new anti-tumor drug, and how could it develop a mysterious new drug that was first launched in Huaguo?

As soon as the muddy water report came out, coupled with the halo of Pfizer and FDA, Ming's Pharmaceutical Group and Qin's Pharmaceutical Company were caught in the ridicule of public opinion.

Even, there is no lack of malicious speculation that Qin Lang obtained the position of laboratory director entirely by relying on Ming Dong's investment to build a laboratory building and send equipment to the First Affiliated Hospital of Zijingang University.

It's just a little boy who eats soft food.

Ming's Pharmaceutical Group's board of directors meeting is halfway through, but it can't go on.

On that day, the stock price of Mingshi Pharmaceutical Group fell by the limit!And that's just the beginning.

Ming's Pharmaceutical Group fell into a huge crisis.

(End of this chapter)